GLA and Fabry disease: Altogether, our RNAi-based genetic platform, which targets the endogenous expression of the CG5731 fly gene (a human GLA homolog) specifically within the brain–midgut axis during aging, may offer a powerful, reliable, multifaceted, dynamic, and sensitive in vivo model system for comprehensively studying FD, to enable efficient drug screening and to illuminate underlying disease mechanisms.